Search results for

An analysis of Medicare data shows that the more money a doctor gets from pharmaceutical companies, the more likely he or she is to prescribe brand-name medications. And that influences cost.

With the tariffs, sanctions and insults, these longtime allies are looking like anything but. As the Turkish lira falls, you may wonder what's going on here — and why it matters. We have answers.

Cases are circulating widely in parts of the U.S. The FDA announced emergency use for convalescent plasma. And when will we have a spit-on-a-stick COVID-19 test?

The judge unseals hundreds of pages of documents related to a now-settled defamation suit brought against Maxwell by one of Jeffrey Epstein's accusers.

A new national poll of teachers from NPR/Ipsos finds broad trepidation about returning to the classroom, with 77% of those surveyed worried about risking their own health.

As moratoriums that staved off utility disconnections cascade to an end, some families face a long winter unsure how they will keep the lights, heat and water on.

Distortion is familiar to most of us — a 'staticky noise,' a 'noisy static.' But in the right hands, its uses can bloom and its rigid contours soften.

Last week, more than 6 million jobless Americans sought unemployment benefits. NPR correspondents look at the rising economic fallout from COVID-19 — and the latest science and political news.

A Jerusalem hotel hosted 180 quarantined COVID-19 patients from different backgrounds. Despite concerns they might clash, some became friends. The biggest test of togetherness came during Passover.

As parts of the country reopen, states are looking to ramp up testing. NPR's health policy, economics and White House correspondents discuss whether states are doing enough to open up safely.